Tengjun Biotechnology Corp. — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9fcb8333-c7ac-4999-9b8c-903dc2f2683b/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $11.3M | 2022-01-01 – 2022-12-31 | evidence 0001213900-23-030342 |
| FY 2021 | $-747.5k | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-016671 |
| FY 2020 | $-690.9k | 2020-01-01 – 2020-12-31 | evidence 0001213900-22-016671 |
| FY 2019 | $-59.9k | 2019-01-01 – 2019-12-31 | evidence 0001213900-20-005061 |
| FY 2018 | $-47.8k | 2018-01-01 – 2018-12-31 | evidence 0001213900-19-003819 |
| FY 2017 | $-19.0k | 2017-01-01 – 2017-12-31 | evidence 0001213900-18-004790 |
| FY 2016 | $-60.7k | 2016-01-01 – 2016-12-31 | evidence 0001213900-17-002815 |
| FY 2015 | $-74.7k | 2015-01-01 – 2015-12-31 | evidence 0001213900-16-012067 |
| FY 2014 | $-108.4k | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-002672 |
| FY 2013 | $-182.4k | 2010-06-28 – 2014-03-31 | evidence 0001477932-14-002907 |
| FY 2012 | $-105.9k | 2010-07-01 – 2013-03-31 | evidence 0001549727-13-000096 |
| FY 2011 | $-86.8k | 2010-06-28 – 2012-03-31 | evidence 0001499785-12-000005 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Tengjun Biotechnology Corp. — all facts · Revenue · Operating Income